Documents | Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

Multiple myeloma - lenalidomide: final appraisal determination

Multiple myeloma - lenalidomide: final appraisal determination information
Multiple myeloma - lenalidomide: final appraisal determination ^{PDF 132.06 KB} 23 April 2009
Response to consultee, commentator and public comments on the ACD and comments from website consultation
Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) issued October 2008 ^{PDF 153.91 KB} 23 April 2009
Response to consultee, commentator and public comments on the second Appraisal Consultation Document (ACD) issued January 2009 ^{PDF 145.07 KB} 23 April 2009
Letter from the Department of health RE: Patient Access Scheme for lenalidomide for the treatment of multiple myeloma ^{PDF 23.63 KB} 23 April 2009
Letter from Celgene sent on 26th February 2009 ^{PDF 29.69 KB} 23 April 2009
Consultee and commentator comments on the ACD
Celgene ^{PDF 30.95 KB} 23 April 2009
Department of Health ^{PDF 9.55 KB} 23 April 2009
Janssen-Cilag ^{PDF 58.65 KB} 23 April 2009
Macmillan Cancer Relief ^{PDF 23.62 KB} 23 April 2009
Myeloma UK ^{PDF 32.73 KB} 23 April 2009
Royal College of Nursing ^{PDF 18 KB} 23 April 2009
Royal College of Pathologists ^{PDF 135.45 KB} 23 April 2009
Royal College of Physicians on behalf of NCRI/RCP/RCR/ACP/JCCO ^{PDF 34.6 KB} 23 April 2009
Sandwell PCT ^{PDF 22.49 KB} 23 April 2009
UK Myeloma Forum and British Society for Haematology ^{PDF 14.42 KB} 23 April 2009
Public comments on the ACD ^{PDF 41.52 KB} 23 April 2009

Multiple myeloma - lenalidomide: appraisal consultation document 2

Multiple myeloma - lenalidomide: appraisal consultation document 2
Multiple myeloma - lenalidomide: appraisal consultation document 2 information
Multiple myeloma - lenalidomide: comments on the ACD issued in October 2008
Extra analysis
Addendum to the ERG report ^{PDF 109.98 KB} 30 January 2009
Addendum to the pre-meeting briefing: end of life - a quantitative exploration ^{PDF 23.66 KB} 30 January 2009
Non-manufacturer comments on the ACD issued in October 2008
Department of Health ^{PDF 6.81 KB} 30 January 2009
Janssen-Cilag ^{PDF 50.77 KB} 30 January 2009
Macmillan Cancer Support ^{PDF 38.58 KB} 30 January 2009
Myeloma UK, Leukaemia CARE, Leukaemia Research and the Rarer Cancers Forum ^{PDF 66.22 KB} 30 January 2009
Royal College of Nursing ^{PDF 18.06 KB} 30 January 2009
Royal College of Physicians, Medical Oncology Joint Special Committee ^{PDF 21.79 KB} 30 January 2009
Royal College of Pathologist ^{PDF 71.31 KB} 30 January 2009
Sandwell PCT ^{PDF 15.4 KB} 30 January 2009
UK Myeloma Forum and British Society for Haematology ^{PDF 16.79 KB} 30 January 2009
Welsh Assembly Government ^{PDF 12.31 KB} 30 January 2009
Manufacturer comments on the ACD issued in October 2008
Celgene response to ACD ^{PDF 101.29 KB} 30 January 2009
Celgene response to ERG lenalidomide report ^{PDF 159.89 KB} 30 January 2009
Letter to DH regarding proposed patient access scheme ^{PDF 138.5 KB} 30 January 2009
Response to questions from NICE on ACD comments ^{PDF 34.31 KB} 30 January 2009
NICE letter to Celgene requesting clarification on their ACD response ^{PDF 28.41 KB} 30 January 2009
Public comments on the ACD issued in October 2008
Letters ^{PDF 1011.58 KB} 30 January 2009
Emails ^{PDF 91.62 KB} 30 January 2009
Web comments ^{PDF 773.72 KB} 30 January 2009
Letter to NICE from the Department of Health RE: Patient Access Scheme for lenalidomide for the treatment of multiple myeloma ^{PDF 23.6 KB} 30 January 2009

Multiple myeloma - lenalidomide: appraisal consultation

Multiple myeloma - lenalidomide: appraisal consultation
Multiple myeloma - lenalidomide: appraisal consultation document information
Multiple myeloma - lenalidomide: evaluation report
Multiple myeloma - lenalidomide: pre-meeting briefing ^{PDF 132.64 KB} 28 October 2008
Multiple myeloma - lenalidomide: evidence review group report ^{PDF 996.74 KB} 28 October 2008
Non-manufacturer submissions
Myeloma UK ^{PDF 53.98 KB} 28 October 2008
Royal College of Nursing ^{PDF 13.66 KB} 28 October 2008
Royal College of Physicians (on behalf of the NCRI, RCP, RCR, ACP and JCCO) ^{PDF 36.22 KB} 28 October 2008
Royal College of Pathologists ^{PDF 124.32 KB} 28 October 2008
UK Myeloma Forum and British Society For Haematology ^{PDF 124.69 KB} 28 October 2008
Manufacturer submission
Celgene ^{PDF 1.44 MB} 28 October 2008
NICE request for clarification ^{PDF 287.7 KB} 28 October 2008
Response from Celgene to request for clarification: Additional information: Part 1 ^{PDF 25.78 KB} 28 October 2008
Response from Celgene to request for clarification: Additional information: Part 2 ^{PDF 16.67 KB} 28 October 2008
Multiple myeloma - lenalidomide: Response from Celgene to request for clarification ^{PDF 287.7 KB} 28 October 2008
Expert written personal statements
Brown ^{PDF 58.56 KB} 28 October 2008
Cavenagh ^{PDF 45.1 KB} 28 October 2008
Low ^{PDF 18.39 KB} 28 October 2008
Schey ^{PDF 41.75 KB} 28 October 2008

Multiple myeloma - lenalidomide: final scope

Multiple myeloma - lenalidomide: final scope ^{PDF 32.17 KB} 12 May 2008

Multiple myeloma - lenalidomide: draft scope (pre-referral)

Multiple myeloma - lenalidomide: draft scope (pre-referral) ^{PDF 33.76 KB} 12 May 2008

Multiple myeloma - lenalidomide: response to comments on the draft scope (pre-referral)

Multiple myeloma - lenalidomide: response to comments on the draft scope (pre-referral) ^{PDF 146.67 KB} 12 May 2008

Multiple myeloma - lenalidomide: provisional matrix of consultees and commentators

Multiple myeloma - lenalidomide: provisional matrix of consultees and commentators ^{PDF 30.17 KB} 10 September 2008

Multiple myeloma - lenalidomide: response to comments on provisional matrix of consultees and commentators

Multiple myeloma - lenalidomide: response to comments on provisional matrix of consultees and commentators ^{PDF 50.62 KB} 12 May 2008